Business Context and Reporting Period
This Form 8-K Current Report for AmpliTech Group, Inc. covers events occurring on January 20, 2026, with the report dated January 26, 2026. The filing primarily details the entry into a material definitive agreement for a registered direct offering and the execution of new director and executive compensation agreements.
Key Financial Metrics and Transaction Details
- Offering Size: 2,230,000 Units sold to five institutional investors.
- Price per Unit: $4.055.
- Gross Proceeds: Approximately $9,042,650 (before fees and expenses).
- Unit Composition: One share of Common Stock, one Series A Right (exercise price $5.00, expires July 18, 2026), and one Series B Right (exercise price $6.00, expires November 20, 2026).
- Placement Fees: 6.0% of aggregate gross proceeds (including proceeds from future exercise of Series Rights) plus up to $15,000 in reimbursable expenses.
- Executive Compensation (Effective Oct 1, 2025):
- Fawad Maqbool (CEO/CTO): $600,000 annually.
- Louisa Sanfratello (CFO): $350,000 annually.
- Jorge Flores (COO): $350,000 annually.
- Director Compensation: Annual compensation of 15,000 Restricted Stock Units (RSUs) for independent directors Andrew Lee, Daniel Mazziota, and Shailesh "Sonny" Modi.
Material Changes and Agreements
The filing reports the execution of a Securities Purchase Agreement for the registered direct offering, with a closing expected on or about January 27, 2026. Additionally, the Company entered into a Lock-Up Agreement restricting directors and executive officers from selling common stock or convertible securities for 60 days following the closing date. The filing also formalizes annual compensation arrangements for key officers and independent directors.
Outlook, Risks, and Contingencies
The Company intends to use the proceeds from the offering, though specific allocation details are not provided in this text. The Series Rights issued in the offering provide purchasers with the same rights as those issued in a previous offering disclosed on October 30, 2025. The filing includes standard disclaimers that representations and warranties in the agreements are for risk allocation between parties and may not reflect materiality standards for general stockholders. No specific forward-looking guidance or risk factors beyond the standard offering terms are detailed in this excerpt.
Investor Verification Checklist
- Verify the final closing date of the offering (expected Jan 27, 2026) and actual net proceeds after deducting the 6.0% placement fee and expenses.
- Review the full text of the Series A and Series B Right Certificates (Exhibits 4.2 and 4.3 referenced from Oct 30, 2025 filing) to understand dilution mechanics upon exercise.
- Confirm the impact of the 60-day lock-up period on insider trading activity post-closing.
- Assess the total equity dilution resulting from the 2,230,000 new shares plus potential future issuance from the Series Rights.
- Check the Company's cash position prior to this offering to evaluate the necessity of the capital raise.